SlideShare a Scribd company logo
1 of 28
Download to read offline
The Quality and Outcomes Framework:
  transparent, transferable, tenable?
      A Niroshan Siriwardena, University of Lincoln
Aims
To provide information to and share
information between the members
Advocacy for Primary Care towards
policymakers and politicians
Support to the development of research
and establishment of a research agenda
Overview

         Transparent

         Transferable

         Tenable




Gillam S, Siriwardena AN (eds) The Quality and Outcomes Framework, Radcliffe,
Oxford 2010
Kings Fund. Improving the quality of care in general practice. 2011.
www.kingsfund.org.uk/publications//gp_inquiry_report.html
Background

     Introduced in 2004 in the UK

    >£1billion per annum

    22% GP income

    Domains: clinical, organisational, patient experience,
    additional services

    Largest natural experiment in pay for performance
    (P4P) in the world
QOF domains
  Clinical                     Organisational
     Secondary prevention of      Records and information
     coronary heart disease       Information for patients
     Cardiovascular disease:      Education and training
     primary prevention           Practice management
     Heart failure                Medicines management
     Stroke & TIA
     Hypertension
     Diabetes mellitus
     COPD
     Epilepsy
     Hypothyroid               Patient experience
     Cancer                       Length of consultations
     Palliative care              Patient survey (access)
     Mental health
     Asthma
     Dementia
     Depression
     Chronic kidney disease    Additional services
     Atrial fibrillation          Cervical screening
     Obesity                      Child health surveillance
     Learning disabilities        Maternity services
     Smoking                      Contraception
Indicators
QOF scores
Records identified        Additional records
through database          identified through
searching (n=575*)        other sources (n=7)



            Records after
            duplicates removed
            (n=423)



            Records screened               Records excluded
            (n=423)                        (n=306)




            Full text articles             Full text articles
            assessed for                   excluded with
            eligibility (n=117)            reasons (n=70)



            Studies included
            (n=47)
The contribution of the QOF
    Health care gains

    Population health and equity

    Costs and cost effectiveness

    Providers, teams and organisations

    Patients’ experiences and views
Health gains?




                                               N Engl J Med 2009;361:368-78.




   Campbell S. N Engl J Med 2009;361:368-78.
“no significant difference in the rate of improvement
   between clinical indicators for which financial
   incentives were provided and those for which they
   were not provided suggests that the pay-for-
   performance program may not necessarily have been
   responsible for the acceleration in improvement”




Campbell Quality of Primary Care in England with the Introduction of
Pay for Performance NEJM 2007
Incentives vs. no incentives




   Campbell S. N Engl J Med 2009;361:368-78.
Population health and equity




                                                    Doran Lancet 2008; 372: 728–36

Dixon, Khachatryan & Boyce. The public health impact, In Gillam & Siriwardena (eds) The
Quality and Outcomes Framework, Radcliffe, Oxford 2010.
Gaming

         Threshold effect

         Ratchet effect


         Output distortion




Kordowicz M and Ashworth M Smoke and mirrors? Informatics opportunities and challenges in
Gillam S, Siriwardena AN (eds) The Quality and Outcomes Framework, Radcliffe, Oxford 2010
Exception reporting
   ‘We try and stick to the rules, I think occasionally people
     get exception reported for reasons that, perhaps, they
     shouldn’t be, but we have very low rates of exception
     reporting.’
     Campbell S: Br J Gen Pract 2011, 61: 183-189.




Kordowicz M and Ashworth M Smoke and mirrors? Informatics opportunities and challenges in
Gillam S, Siriwardena AN (eds) The Quality and Outcomes Framework, Radcliffe, Oxford 2010
Cost effectiveness
      No relationship between pay and health gain
      Cost effectiveness evidence for 12 indicators in the 2006
      revised contract with direct therapeutic effect
       3 most cost-effective indicators were:
           ACEI/ARB for CKD
           Anticoagulants for AF and
           Beta-blockers for CHD




Fleetcroft RBr J Gen Pract 2010, 60: e345-e352.
Practice and organisation

         Some patients will come to you and they’ll plead with you,
         ‘Please don’t give me any tablets, I’ll bring my blood
         pressure down, I’ll do everything. I’ll bring it down’, and
         again they’re not horrendously high, they’re like say 140/90
         or whatever ... but we’re saying to them ‘well, look we’ve
         checked it three times now and it remains raised, you’re
         clinically classed as hypertensive, we follow these
         guidelines and this is what we should be doing with you’.
         (Nurse practitioner)

        Every day I come in I check (performance) ... I’m a chaser
        ... if you’re a chaser you have to chase yourself though.
        ‘Cos you’ve no credibility if you don’t deliver.’ (GP partner).

Checkland & Harrison. In Gillam & Siriwardena (eds) The Quality and Outcomes
Framework, Radcliffe, Oxford 2010. Checkland K, Qual Prim Care 2010, 18: 139-
146.
Clinical behaviour
    ‘And there have been 1 or 2 occasions where I went
    through the cholesterol, the depression, the CHD, and
    everything else, and “Oh, that’s wonderful, I’m finished
    now,” and the patient said “Well, what about my foot then?”
    “What foot”?’ [GP]




    I feel actually I’m looking at the patient less than I used to,
    which is a shame.… I have to say to them, “I’m sorry, I’ve
    got to look at the computer as well and type in while you’re
    talking to me” (PN).




  Campbell SM. Ann Fam Med 2008, 6: 228-234.
Patient experience

   “A slim, active 69-year-old patient attending for influenza
   vaccine was faced with questions about diet, smoking,
   exercise and alcohol consumption. There was no
   explanation for why these questions were asked; they
   seemed irrelevant to having a ‘flu vaccine.’

   Blood pressure and weight had to be recorded and a
   cholesterol test organised. A short appointment lasted
   almost 15 minutes without the patient having the opportunity
   to ask a question about any aspect of ‘flu vaccine.”




   Wilkie. Does the patient always benefit? In Gillam & Siriwardena (eds)
   The Quality and Outcomes Framework, Radcliffe, Oxford 2010
Continuity




   Campbell S. N Engl J Med 2009;361:368-78.
Inverse care law




       Heath, I. et al. BMJ 2007;335:1075-1076
“That any sane nation, having observed that you could
  provide for the supply of bread by giving bakers a
  pecuniary interest in baking for you, should go on to
  give a surgeon a pecuniary interest in cutting off
  your leg, is enough to make one despair ...” George
  Bernard Shaw
Successes and failures
    Improved processes, data and analysis

    Initial health benefits for individuals and populations

    Some narrowing of inequalities in processes of health care

    Opportunity costs contested

    Unintended consequences

    Negative effect on care




   Starfield & Mangin. An international perspective on the basis of P4P. In Gillam &
   Siriwardena (eds) The Quality and Outcomes Framework, Radcliffe, Oxford 2010
Quality then…
  "The overall state of general practice is bad and
  still deteriorating“

  "The development of other medical services ... has
  resulted ... in wide departure from both the idea
  and the ideal of family doctoring“

  "Some [working conditions] are bad enough to
  require condemnation in the public interest"
Now…

       Quality of most care in general practice is good

       Wide variations in performance and gaps in the quality of
       care both within and between practices

       Many working in general practice are not aware of
       variations, gaps and the significant opportunities for
       general practice to improve the quality of care it
       provides.




Kings Fund. Improving the quality of care in general practice. 2011.
www.kingsfund.org.uk/publications//gp_inquiry_report.html
'What do "targets" accomplish?
                  Nothing.
                  Wrong: their accomplishment is
                  negative.‘

                  'Management by numerical goal is
                  an attempt to manage without
                  knowledge of what to
                  do'.


W Edwards Deming 1900-1993
Conclusions and ways forward
1. niro siriwardena qof transparency

More Related Content

What's hot

Geriatric Cardio-Oncology
Geriatric Cardio-OncologyGeriatric Cardio-Oncology
Geriatric Cardio-OncologyCamilla Wong
 
Is clinician gestalt undervalued in chest pain assessment in ED
Is clinician gestalt undervalued in chest pain assessment in EDIs clinician gestalt undervalued in chest pain assessment in ED
Is clinician gestalt undervalued in chest pain assessment in EDkellyam18
 
J2016 - Tecson et al AJC Impact of EECP on Heart Failure Rehospitalization
J2016 - Tecson et al AJC Impact of EECP on Heart Failure RehospitalizationJ2016 - Tecson et al AJC Impact of EECP on Heart Failure Rehospitalization
J2016 - Tecson et al AJC Impact of EECP on Heart Failure RehospitalizationEmily Hu
 
Depression and cognitive impairment in peritoneal dialysis a multicenter cros...
Depression and cognitive impairment in peritoneal dialysis a multicenter cros...Depression and cognitive impairment in peritoneal dialysis a multicenter cros...
Depression and cognitive impairment in peritoneal dialysis a multicenter cros...Lilin Rosyanti Poltekkes kemenkes kendari
 
Consensus overview on ME/CFS
Consensus overview on ME/CFSConsensus overview on ME/CFS
Consensus overview on ME/CFSdegarden
 
A service improvement focused on frailty using an R&D approach, pop up uni, 3...
A service improvement focused on frailty using an R&D approach, pop up uni, 3...A service improvement focused on frailty using an R&D approach, pop up uni, 3...
A service improvement focused on frailty using an R&D approach, pop up uni, 3...NHS England
 
Meta analisis of statin
Meta analisis of statinMeta analisis of statin
Meta analisis of statinEmy Oktaviani
 
Transportation and Total Health - Arlington Mobility Lab Lunch and Learn
Transportation and Total Health - Arlington Mobility Lab Lunch and LearnTransportation and Total Health - Arlington Mobility Lab Lunch and Learn
Transportation and Total Health - Arlington Mobility Lab Lunch and LearnTed Eytan, MD, MS, MPH
 
Hart gwep presentation slides
Hart gwep presentation slidesHart gwep presentation slides
Hart gwep presentation slidesSDGWEP
 
Geriatric Oncology
Geriatric OncologyGeriatric Oncology
Geriatric OncologyCamilla Wong
 
Ebm talk-general-mar99-ppt95
Ebm talk-general-mar99-ppt95Ebm talk-general-mar99-ppt95
Ebm talk-general-mar99-ppt95rubenroa
 
Gwen O´Shaughnessy - USA - Wednesday 30 - Oral Presentations Misc. B
Gwen O´Shaughnessy - USA - Wednesday 30 - Oral Presentations Misc. BGwen O´Shaughnessy - USA - Wednesday 30 - Oral Presentations Misc. B
Gwen O´Shaughnessy - USA - Wednesday 30 - Oral Presentations Misc. Bincucai_isodp
 
ICU delirium - critical factors and liberation bundles - Pratik Pandharipande...
ICU delirium - critical factors and liberation bundles - Pratik Pandharipande...ICU delirium - critical factors and liberation bundles - Pratik Pandharipande...
ICU delirium - critical factors and liberation bundles - Pratik Pandharipande...scanFOAM
 
The Changing Face of Trauma Care
The Changing Face of Trauma Care The Changing Face of Trauma Care
The Changing Face of Trauma Care Camilla Wong
 
10 joyce neumann
10 joyce neumann10 joyce neumann
10 joyce neumannspa718
 

What's hot (20)

Geriatric Cardio-Oncology
Geriatric Cardio-OncologyGeriatric Cardio-Oncology
Geriatric Cardio-Oncology
 
Is clinician gestalt undervalued in chest pain assessment in ED
Is clinician gestalt undervalued in chest pain assessment in EDIs clinician gestalt undervalued in chest pain assessment in ED
Is clinician gestalt undervalued in chest pain assessment in ED
 
Impact of unhealthy behavior on per capita costs
Impact of unhealthy behavior on per capita costsImpact of unhealthy behavior on per capita costs
Impact of unhealthy behavior on per capita costs
 
J2016 - Tecson et al AJC Impact of EECP on Heart Failure Rehospitalization
J2016 - Tecson et al AJC Impact of EECP on Heart Failure RehospitalizationJ2016 - Tecson et al AJC Impact of EECP on Heart Failure Rehospitalization
J2016 - Tecson et al AJC Impact of EECP on Heart Failure Rehospitalization
 
Depression and cognitive impairment in peritoneal dialysis a multicenter cros...
Depression and cognitive impairment in peritoneal dialysis a multicenter cros...Depression and cognitive impairment in peritoneal dialysis a multicenter cros...
Depression and cognitive impairment in peritoneal dialysis a multicenter cros...
 
Consensus overview on ME/CFS
Consensus overview on ME/CFSConsensus overview on ME/CFS
Consensus overview on ME/CFS
 
A service improvement focused on frailty using an R&D approach, pop up uni, 3...
A service improvement focused on frailty using an R&D approach, pop up uni, 3...A service improvement focused on frailty using an R&D approach, pop up uni, 3...
A service improvement focused on frailty using an R&D approach, pop up uni, 3...
 
Meta analisis of statin
Meta analisis of statinMeta analisis of statin
Meta analisis of statin
 
Transportation and Total Health - Arlington Mobility Lab Lunch and Learn
Transportation and Total Health - Arlington Mobility Lab Lunch and LearnTransportation and Total Health - Arlington Mobility Lab Lunch and Learn
Transportation and Total Health - Arlington Mobility Lab Lunch and Learn
 
Hart gwep presentation slides
Hart gwep presentation slidesHart gwep presentation slides
Hart gwep presentation slides
 
Aderenta si riscul cardiovascul
Aderenta si riscul cardiovasculAderenta si riscul cardiovascul
Aderenta si riscul cardiovascul
 
Geriatric oncology 2019
Geriatric oncology 2019Geriatric oncology 2019
Geriatric oncology 2019
 
Coplin_CV_bio_060914
Coplin_CV_bio_060914Coplin_CV_bio_060914
Coplin_CV_bio_060914
 
Geriatric Oncology
Geriatric OncologyGeriatric Oncology
Geriatric Oncology
 
Ebm talk-general-mar99-ppt95
Ebm talk-general-mar99-ppt95Ebm talk-general-mar99-ppt95
Ebm talk-general-mar99-ppt95
 
Gwen O´Shaughnessy - USA - Wednesday 30 - Oral Presentations Misc. B
Gwen O´Shaughnessy - USA - Wednesday 30 - Oral Presentations Misc. BGwen O´Shaughnessy - USA - Wednesday 30 - Oral Presentations Misc. B
Gwen O´Shaughnessy - USA - Wednesday 30 - Oral Presentations Misc. B
 
ICU delirium - critical factors and liberation bundles - Pratik Pandharipande...
ICU delirium - critical factors and liberation bundles - Pratik Pandharipande...ICU delirium - critical factors and liberation bundles - Pratik Pandharipande...
ICU delirium - critical factors and liberation bundles - Pratik Pandharipande...
 
The Changing Face of Trauma Care
The Changing Face of Trauma Care The Changing Face of Trauma Care
The Changing Face of Trauma Care
 
The ageing patient and surgeon
The ageing patient and surgeon  The ageing patient and surgeon
The ageing patient and surgeon
 
10 joyce neumann
10 joyce neumann10 joyce neumann
10 joyce neumann
 

Viewers also liked

Sessie 4 ketentransparantie stannie driessen en hedi ter braak
Sessie 4 ketentransparantie   stannie driessen en hedi ter braakSessie 4 ketentransparantie   stannie driessen en hedi ter braak
Sessie 4 ketentransparantie stannie driessen en hedi ter braakDe Eerstelijns
 
4. hans van bijsterveldt nut en noodzaak van vergelijkbare kwaliteit in de ...
4. hans van bijsterveldt   nut en noodzaak van vergelijkbare kwaliteit in de ...4. hans van bijsterveldt   nut en noodzaak van vergelijkbare kwaliteit in de ...
4. hans van bijsterveldt nut en noodzaak van vergelijkbare kwaliteit in de ...De Eerstelijns
 
6. hans bilo benchmarken op basis van indicatoren
6. hans bilo   benchmarken op basis van indicatoren6. hans bilo   benchmarken op basis van indicatoren
6. hans bilo benchmarken op basis van indicatorenDe Eerstelijns
 
Sessie 2 benchmarking irma vd pluijm en marianne meulenpas
Sessie 2 benchmarking   irma vd pluijm en marianne meulenpasSessie 2 benchmarking   irma vd pluijm en marianne meulenpas
Sessie 2 benchmarking irma vd pluijm en marianne meulenpasDe Eerstelijns
 
Substitutiecongres presentatie: Johan Polder
Substitutiecongres presentatie:  Johan PolderSubstitutiecongres presentatie:  Johan Polder
Substitutiecongres presentatie: Johan PolderDe Eerstelijns
 
Sessie 3 door clienten bekeken michael rutgers
Sessie 3 door clienten bekeken   michael rutgersSessie 3 door clienten bekeken   michael rutgers
Sessie 3 door clienten bekeken michael rutgersDe Eerstelijns
 
9. marc bruijnzeels indicatoren in de eerste lijn wat en hoe
9. marc bruijnzeels   indicatoren in de eerste lijn wat en hoe9. marc bruijnzeels   indicatoren in de eerste lijn wat en hoe
9. marc bruijnzeels indicatoren in de eerste lijn wat en hoeDe Eerstelijns
 
Substitutiecongres: presentatie Aldien Poll
Substitutiecongres: presentatie Aldien PollSubstitutiecongres: presentatie Aldien Poll
Substitutiecongres: presentatie Aldien PollDe Eerstelijns
 
3. guus schrijvers kwaliteitsindicatoren in de eerstelijn
3. guus schrijvers   kwaliteitsindicatoren in de eerstelijn3. guus schrijvers   kwaliteitsindicatoren in de eerstelijn
3. guus schrijvers kwaliteitsindicatoren in de eerstelijnDe Eerstelijns
 

Viewers also liked (9)

Sessie 4 ketentransparantie stannie driessen en hedi ter braak
Sessie 4 ketentransparantie   stannie driessen en hedi ter braakSessie 4 ketentransparantie   stannie driessen en hedi ter braak
Sessie 4 ketentransparantie stannie driessen en hedi ter braak
 
4. hans van bijsterveldt nut en noodzaak van vergelijkbare kwaliteit in de ...
4. hans van bijsterveldt   nut en noodzaak van vergelijkbare kwaliteit in de ...4. hans van bijsterveldt   nut en noodzaak van vergelijkbare kwaliteit in de ...
4. hans van bijsterveldt nut en noodzaak van vergelijkbare kwaliteit in de ...
 
6. hans bilo benchmarken op basis van indicatoren
6. hans bilo   benchmarken op basis van indicatoren6. hans bilo   benchmarken op basis van indicatoren
6. hans bilo benchmarken op basis van indicatoren
 
Sessie 2 benchmarking irma vd pluijm en marianne meulenpas
Sessie 2 benchmarking   irma vd pluijm en marianne meulenpasSessie 2 benchmarking   irma vd pluijm en marianne meulenpas
Sessie 2 benchmarking irma vd pluijm en marianne meulenpas
 
Substitutiecongres presentatie: Johan Polder
Substitutiecongres presentatie:  Johan PolderSubstitutiecongres presentatie:  Johan Polder
Substitutiecongres presentatie: Johan Polder
 
Sessie 3 door clienten bekeken michael rutgers
Sessie 3 door clienten bekeken   michael rutgersSessie 3 door clienten bekeken   michael rutgers
Sessie 3 door clienten bekeken michael rutgers
 
9. marc bruijnzeels indicatoren in de eerste lijn wat en hoe
9. marc bruijnzeels   indicatoren in de eerste lijn wat en hoe9. marc bruijnzeels   indicatoren in de eerste lijn wat en hoe
9. marc bruijnzeels indicatoren in de eerste lijn wat en hoe
 
Substitutiecongres: presentatie Aldien Poll
Substitutiecongres: presentatie Aldien PollSubstitutiecongres: presentatie Aldien Poll
Substitutiecongres: presentatie Aldien Poll
 
3. guus schrijvers kwaliteitsindicatoren in de eerstelijn
3. guus schrijvers   kwaliteitsindicatoren in de eerstelijn3. guus schrijvers   kwaliteitsindicatoren in de eerstelijn
3. guus schrijvers kwaliteitsindicatoren in de eerstelijn
 

Similar to 1. niro siriwardena qof transparency

Stephen Gillam presentation WSPCR 2011
Stephen Gillam presentation WSPCR 2011Stephen Gillam presentation WSPCR 2011
Stephen Gillam presentation WSPCR 2011angewatkins
 
Why improving the patient experience with advanced care options matters
Why improving the patient experience with advanced care options mattersWhy improving the patient experience with advanced care options matters
Why improving the patient experience with advanced care options mattersdrucsamal
 
Competing in Outcomes World - Chris Bogan Keynote - Final
Competing in Outcomes World - Chris Bogan Keynote - FinalCompeting in Outcomes World - Chris Bogan Keynote - Final
Competing in Outcomes World - Chris Bogan Keynote - FinalChris Bogan
 
So You Think You Can Only Treat Illness
So You Think You Can Only Treat IllnessSo You Think You Can Only Treat Illness
So You Think You Can Only Treat IllnessNHSScotlandEvent
 
Turbo Charge Quality
Turbo Charge QualityTurbo Charge Quality
Turbo Charge QualitySCBHealth
 
Asra defining value may 2015
Asra defining value may 2015Asra defining value may 2015
Asra defining value may 2015Colin McCartney
 
Slides from Focus on Frailty 2019 conference main plenary sessions
Slides from Focus on Frailty 2019 conference main plenary sessionsSlides from Focus on Frailty 2019 conference main plenary sessions
Slides from Focus on Frailty 2019 conference main plenary sessionsHealth Innovation Wessex
 
Quality innovation for superior patient care
Quality innovation for superior patient careQuality innovation for superior patient care
Quality innovation for superior patient careMED E Talks
 
Turbo Charging Quality
Turbo Charging QualityTurbo Charging Quality
Turbo Charging QualitySCBHealth
 
Lipid Screening in Childhood for Detection of Multifactorial Dyslipidemia
Lipid Screening in Childhood for Detection of Multifactorial DyslipidemiaLipid Screening in Childhood for Detection of Multifactorial Dyslipidemia
Lipid Screening in Childhood for Detection of Multifactorial DyslipidemiaGlobal Medical Cures™
 
Published Research, Flawed, Misleading, Nefarious - Use of Reporting Guidelin...
Published Research, Flawed, Misleading, Nefarious - Use of Reporting Guidelin...Published Research, Flawed, Misleading, Nefarious - Use of Reporting Guidelin...
Published Research, Flawed, Misleading, Nefarious - Use of Reporting Guidelin...John Hoey
 
Measuring what matters to patients: concepts and cases
Measuring what matters to patients: concepts and casesMeasuring what matters to patients: concepts and cases
Measuring what matters to patients: concepts and casesThe Health Foundation
 
Designing Causal Inference Studies Using Real-World Data
Designing Causal Inference Studies Using Real-World DataDesigning Causal Inference Studies Using Real-World Data
Designing Causal Inference Studies Using Real-World DataInsideScientific
 
What Outcomes Matter in Cancer? A Literature Review
What Outcomes Matter in Cancer? A Literature ReviewWhat Outcomes Matter in Cancer? A Literature Review
What Outcomes Matter in Cancer? A Literature ReviewOffice of Health Economics
 
The role of primary care in the management of crf patients
The role of primary care in the management of crf patientsThe role of primary care in the management of crf patients
The role of primary care in the management of crf patientsIvan De Paz Mejia
 
Understanding the Current Quality of Diabetes Care and Effective Approaches t...
Understanding the Current Quality of Diabetes Care and Effective Approaches t...Understanding the Current Quality of Diabetes Care and Effective Approaches t...
Understanding the Current Quality of Diabetes Care and Effective Approaches t...National Aboriginal Health Organization
 
Population Health Management & Volume To Value Based Care
Population Health Management & Volume To Value Based CarePopulation Health Management & Volume To Value Based Care
Population Health Management & Volume To Value Based CareIFAH
 

Similar to 1. niro siriwardena qof transparency (20)

Stephen Gillam presentation WSPCR 2011
Stephen Gillam presentation WSPCR 2011Stephen Gillam presentation WSPCR 2011
Stephen Gillam presentation WSPCR 2011
 
Why improving the patient experience with advanced care options matters
Why improving the patient experience with advanced care options mattersWhy improving the patient experience with advanced care options matters
Why improving the patient experience with advanced care options matters
 
Competing in Outcomes World - Chris Bogan Keynote - Final
Competing in Outcomes World - Chris Bogan Keynote - FinalCompeting in Outcomes World - Chris Bogan Keynote - Final
Competing in Outcomes World - Chris Bogan Keynote - Final
 
Oncology Treatment Guidelines : The Rules and Rationale
Oncology  Treatment Guidelines :The Rules and RationaleOncology  Treatment Guidelines :The Rules and Rationale
Oncology Treatment Guidelines : The Rules and Rationale
 
So You Think You Can Only Treat Illness
So You Think You Can Only Treat IllnessSo You Think You Can Only Treat Illness
So You Think You Can Only Treat Illness
 
Turbo Charge Quality
Turbo Charge QualityTurbo Charge Quality
Turbo Charge Quality
 
Asra defining value may 2015
Asra defining value may 2015Asra defining value may 2015
Asra defining value may 2015
 
Slides from Focus on Frailty 2019 conference main plenary sessions
Slides from Focus on Frailty 2019 conference main plenary sessionsSlides from Focus on Frailty 2019 conference main plenary sessions
Slides from Focus on Frailty 2019 conference main plenary sessions
 
Quality innovation for superior patient care
Quality innovation for superior patient careQuality innovation for superior patient care
Quality innovation for superior patient care
 
Turbo Charging Quality
Turbo Charging QualityTurbo Charging Quality
Turbo Charging Quality
 
Lipid Screening in Childhood for Detection of Multifactorial Dyslipidemia
Lipid Screening in Childhood for Detection of Multifactorial DyslipidemiaLipid Screening in Childhood for Detection of Multifactorial Dyslipidemia
Lipid Screening in Childhood for Detection of Multifactorial Dyslipidemia
 
Published Research, Flawed, Misleading, Nefarious - Use of Reporting Guidelin...
Published Research, Flawed, Misleading, Nefarious - Use of Reporting Guidelin...Published Research, Flawed, Misleading, Nefarious - Use of Reporting Guidelin...
Published Research, Flawed, Misleading, Nefarious - Use of Reporting Guidelin...
 
Measuring what matters to patients: concepts and cases
Measuring what matters to patients: concepts and casesMeasuring what matters to patients: concepts and cases
Measuring what matters to patients: concepts and cases
 
Aeha cea- shaw
Aeha   cea- shawAeha   cea- shaw
Aeha cea- shaw
 
Designing Causal Inference Studies Using Real-World Data
Designing Causal Inference Studies Using Real-World DataDesigning Causal Inference Studies Using Real-World Data
Designing Causal Inference Studies Using Real-World Data
 
What Outcomes Matter in Cancer? A Literature Review
What Outcomes Matter in Cancer? A Literature ReviewWhat Outcomes Matter in Cancer? A Literature Review
What Outcomes Matter in Cancer? A Literature Review
 
The role of primary care in the management of crf patients
The role of primary care in the management of crf patientsThe role of primary care in the management of crf patients
The role of primary care in the management of crf patients
 
Analytics leads to improved quality and performance
Analytics leads to improved quality and performanceAnalytics leads to improved quality and performance
Analytics leads to improved quality and performance
 
Understanding the Current Quality of Diabetes Care and Effective Approaches t...
Understanding the Current Quality of Diabetes Care and Effective Approaches t...Understanding the Current Quality of Diabetes Care and Effective Approaches t...
Understanding the Current Quality of Diabetes Care and Effective Approaches t...
 
Population Health Management & Volume To Value Based Care
Population Health Management & Volume To Value Based CarePopulation Health Management & Volume To Value Based Care
Population Health Management & Volume To Value Based Care
 

More from De Eerstelijns

Substitutiecongres presentatie karel rosmalen
Substitutiecongres presentatie karel rosmalenSubstitutiecongres presentatie karel rosmalen
Substitutiecongres presentatie karel rosmalenDe Eerstelijns
 
Substitutiecongres: presentatie Jan Erik de Wildt
Substitutiecongres: presentatie Jan Erik de WildtSubstitutiecongres: presentatie Jan Erik de Wildt
Substitutiecongres: presentatie Jan Erik de WildtDe Eerstelijns
 
Substitutiecongres: presentatie Nicole Kien
Substitutiecongres: presentatie  Nicole KienSubstitutiecongres: presentatie  Nicole Kien
Substitutiecongres: presentatie Nicole KienDe Eerstelijns
 
Substitutiecongres: presentatie Marc Bruijnzeels
Substitutiecongres: presentatie Marc BruijnzeelsSubstitutiecongres: presentatie Marc Bruijnzeels
Substitutiecongres: presentatie Marc BruijnzeelsDe Eerstelijns
 
7. aldien poll verzekeraars en transparantie
7. aldien poll   verzekeraars en transparantie7. aldien poll   verzekeraars en transparantie
7. aldien poll verzekeraars en transparantieDe Eerstelijns
 
Sessie 3 door clienten bekeken jan benedictus
Sessie 3 door clienten bekeken   jan benedictusSessie 3 door clienten bekeken   jan benedictus
Sessie 3 door clienten bekeken jan benedictusDe Eerstelijns
 
Sessie 1 business intelligence amon vd borg en dennis vd rijt
Sessie 1 business intelligence   amon vd borg en dennis vd rijtSessie 1 business intelligence   amon vd borg en dennis vd rijt
Sessie 1 business intelligence amon vd borg en dennis vd rijtDe Eerstelijns
 
8. anne van popta & arian prins geen transparantie zonder ict innovatie
8. anne van popta & arian prins   geen transparantie zonder ict innovatie8. anne van popta & arian prins   geen transparantie zonder ict innovatie
8. anne van popta & arian prins geen transparantie zonder ict innovatieDe Eerstelijns
 
5. judith van der meer grenzen aan transparantie
5. judith van der meer   grenzen aan transparantie5. judith van der meer   grenzen aan transparantie
5. judith van der meer grenzen aan transparantieDe Eerstelijns
 
2. gert westert de kwaliteit van de eerstelijn
2. gert westert   de kwaliteit van de eerstelijn2. gert westert   de kwaliteit van de eerstelijn
2. gert westert de kwaliteit van de eerstelijnDe Eerstelijns
 
Sessie 5 keteninformatie erik bos sho
Sessie 5 keteninformatie   erik bos shoSessie 5 keteninformatie   erik bos sho
Sessie 5 keteninformatie erik bos shoDe Eerstelijns
 

More from De Eerstelijns (11)

Substitutiecongres presentatie karel rosmalen
Substitutiecongres presentatie karel rosmalenSubstitutiecongres presentatie karel rosmalen
Substitutiecongres presentatie karel rosmalen
 
Substitutiecongres: presentatie Jan Erik de Wildt
Substitutiecongres: presentatie Jan Erik de WildtSubstitutiecongres: presentatie Jan Erik de Wildt
Substitutiecongres: presentatie Jan Erik de Wildt
 
Substitutiecongres: presentatie Nicole Kien
Substitutiecongres: presentatie  Nicole KienSubstitutiecongres: presentatie  Nicole Kien
Substitutiecongres: presentatie Nicole Kien
 
Substitutiecongres: presentatie Marc Bruijnzeels
Substitutiecongres: presentatie Marc BruijnzeelsSubstitutiecongres: presentatie Marc Bruijnzeels
Substitutiecongres: presentatie Marc Bruijnzeels
 
7. aldien poll verzekeraars en transparantie
7. aldien poll   verzekeraars en transparantie7. aldien poll   verzekeraars en transparantie
7. aldien poll verzekeraars en transparantie
 
Sessie 3 door clienten bekeken jan benedictus
Sessie 3 door clienten bekeken   jan benedictusSessie 3 door clienten bekeken   jan benedictus
Sessie 3 door clienten bekeken jan benedictus
 
Sessie 1 business intelligence amon vd borg en dennis vd rijt
Sessie 1 business intelligence   amon vd borg en dennis vd rijtSessie 1 business intelligence   amon vd borg en dennis vd rijt
Sessie 1 business intelligence amon vd borg en dennis vd rijt
 
8. anne van popta & arian prins geen transparantie zonder ict innovatie
8. anne van popta & arian prins   geen transparantie zonder ict innovatie8. anne van popta & arian prins   geen transparantie zonder ict innovatie
8. anne van popta & arian prins geen transparantie zonder ict innovatie
 
5. judith van der meer grenzen aan transparantie
5. judith van der meer   grenzen aan transparantie5. judith van der meer   grenzen aan transparantie
5. judith van der meer grenzen aan transparantie
 
2. gert westert de kwaliteit van de eerstelijn
2. gert westert   de kwaliteit van de eerstelijn2. gert westert   de kwaliteit van de eerstelijn
2. gert westert de kwaliteit van de eerstelijn
 
Sessie 5 keteninformatie erik bos sho
Sessie 5 keteninformatie   erik bos shoSessie 5 keteninformatie   erik bos sho
Sessie 5 keteninformatie erik bos sho
 

1. niro siriwardena qof transparency

  • 1. The Quality and Outcomes Framework: transparent, transferable, tenable? A Niroshan Siriwardena, University of Lincoln
  • 2. Aims To provide information to and share information between the members Advocacy for Primary Care towards policymakers and politicians Support to the development of research and establishment of a research agenda
  • 3. Overview Transparent Transferable Tenable Gillam S, Siriwardena AN (eds) The Quality and Outcomes Framework, Radcliffe, Oxford 2010 Kings Fund. Improving the quality of care in general practice. 2011. www.kingsfund.org.uk/publications//gp_inquiry_report.html
  • 4. Background Introduced in 2004 in the UK >£1billion per annum 22% GP income Domains: clinical, organisational, patient experience, additional services Largest natural experiment in pay for performance (P4P) in the world
  • 5. QOF domains Clinical Organisational Secondary prevention of Records and information coronary heart disease Information for patients Cardiovascular disease: Education and training primary prevention Practice management Heart failure Medicines management Stroke & TIA Hypertension Diabetes mellitus COPD Epilepsy Hypothyroid Patient experience Cancer Length of consultations Palliative care Patient survey (access) Mental health Asthma Dementia Depression Chronic kidney disease Additional services Atrial fibrillation Cervical screening Obesity Child health surveillance Learning disabilities Maternity services Smoking Contraception
  • 8. Records identified Additional records through database identified through searching (n=575*) other sources (n=7) Records after duplicates removed (n=423) Records screened Records excluded (n=423) (n=306) Full text articles Full text articles assessed for excluded with eligibility (n=117) reasons (n=70) Studies included (n=47)
  • 9. The contribution of the QOF Health care gains Population health and equity Costs and cost effectiveness Providers, teams and organisations Patients’ experiences and views
  • 10. Health gains? N Engl J Med 2009;361:368-78. Campbell S. N Engl J Med 2009;361:368-78.
  • 11. “no significant difference in the rate of improvement between clinical indicators for which financial incentives were provided and those for which they were not provided suggests that the pay-for- performance program may not necessarily have been responsible for the acceleration in improvement” Campbell Quality of Primary Care in England with the Introduction of Pay for Performance NEJM 2007
  • 12. Incentives vs. no incentives Campbell S. N Engl J Med 2009;361:368-78.
  • 13. Population health and equity Doran Lancet 2008; 372: 728–36 Dixon, Khachatryan & Boyce. The public health impact, In Gillam & Siriwardena (eds) The Quality and Outcomes Framework, Radcliffe, Oxford 2010.
  • 14. Gaming Threshold effect Ratchet effect Output distortion Kordowicz M and Ashworth M Smoke and mirrors? Informatics opportunities and challenges in Gillam S, Siriwardena AN (eds) The Quality and Outcomes Framework, Radcliffe, Oxford 2010
  • 15. Exception reporting ‘We try and stick to the rules, I think occasionally people get exception reported for reasons that, perhaps, they shouldn’t be, but we have very low rates of exception reporting.’ Campbell S: Br J Gen Pract 2011, 61: 183-189. Kordowicz M and Ashworth M Smoke and mirrors? Informatics opportunities and challenges in Gillam S, Siriwardena AN (eds) The Quality and Outcomes Framework, Radcliffe, Oxford 2010
  • 16. Cost effectiveness No relationship between pay and health gain Cost effectiveness evidence for 12 indicators in the 2006 revised contract with direct therapeutic effect 3 most cost-effective indicators were: ACEI/ARB for CKD Anticoagulants for AF and Beta-blockers for CHD Fleetcroft RBr J Gen Pract 2010, 60: e345-e352.
  • 17. Practice and organisation Some patients will come to you and they’ll plead with you, ‘Please don’t give me any tablets, I’ll bring my blood pressure down, I’ll do everything. I’ll bring it down’, and again they’re not horrendously high, they’re like say 140/90 or whatever ... but we’re saying to them ‘well, look we’ve checked it three times now and it remains raised, you’re clinically classed as hypertensive, we follow these guidelines and this is what we should be doing with you’. (Nurse practitioner) Every day I come in I check (performance) ... I’m a chaser ... if you’re a chaser you have to chase yourself though. ‘Cos you’ve no credibility if you don’t deliver.’ (GP partner). Checkland & Harrison. In Gillam & Siriwardena (eds) The Quality and Outcomes Framework, Radcliffe, Oxford 2010. Checkland K, Qual Prim Care 2010, 18: 139- 146.
  • 18. Clinical behaviour ‘And there have been 1 or 2 occasions where I went through the cholesterol, the depression, the CHD, and everything else, and “Oh, that’s wonderful, I’m finished now,” and the patient said “Well, what about my foot then?” “What foot”?’ [GP] I feel actually I’m looking at the patient less than I used to, which is a shame.… I have to say to them, “I’m sorry, I’ve got to look at the computer as well and type in while you’re talking to me” (PN). Campbell SM. Ann Fam Med 2008, 6: 228-234.
  • 19. Patient experience “A slim, active 69-year-old patient attending for influenza vaccine was faced with questions about diet, smoking, exercise and alcohol consumption. There was no explanation for why these questions were asked; they seemed irrelevant to having a ‘flu vaccine.’ Blood pressure and weight had to be recorded and a cholesterol test organised. A short appointment lasted almost 15 minutes without the patient having the opportunity to ask a question about any aspect of ‘flu vaccine.” Wilkie. Does the patient always benefit? In Gillam & Siriwardena (eds) The Quality and Outcomes Framework, Radcliffe, Oxford 2010
  • 20. Continuity Campbell S. N Engl J Med 2009;361:368-78.
  • 21. Inverse care law Heath, I. et al. BMJ 2007;335:1075-1076
  • 22. “That any sane nation, having observed that you could provide for the supply of bread by giving bakers a pecuniary interest in baking for you, should go on to give a surgeon a pecuniary interest in cutting off your leg, is enough to make one despair ...” George Bernard Shaw
  • 23. Successes and failures Improved processes, data and analysis Initial health benefits for individuals and populations Some narrowing of inequalities in processes of health care Opportunity costs contested Unintended consequences Negative effect on care Starfield & Mangin. An international perspective on the basis of P4P. In Gillam & Siriwardena (eds) The Quality and Outcomes Framework, Radcliffe, Oxford 2010
  • 24. Quality then… "The overall state of general practice is bad and still deteriorating“ "The development of other medical services ... has resulted ... in wide departure from both the idea and the ideal of family doctoring“ "Some [working conditions] are bad enough to require condemnation in the public interest"
  • 25. Now… Quality of most care in general practice is good Wide variations in performance and gaps in the quality of care both within and between practices Many working in general practice are not aware of variations, gaps and the significant opportunities for general practice to improve the quality of care it provides. Kings Fund. Improving the quality of care in general practice. 2011. www.kingsfund.org.uk/publications//gp_inquiry_report.html
  • 26. 'What do "targets" accomplish? Nothing. Wrong: their accomplishment is negative.‘ 'Management by numerical goal is an attempt to manage without knowledge of what to do'. W Edwards Deming 1900-1993